🇺🇸 FDA
Pipeline program

Placebo

BCX4208-204

Phase 2 small_molecule completed

Quick answer

Placebo for Gout is a Phase 2 program (small_molecule) at Biocryst with 3 ClinicalTrials.gov record(s).

Program details

Company
Biocryst
Indication
Gout
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials